5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Non-proliferative and Proliferative Lesions of the Non-human Primate ( M. fascicularis )

      review-article
      1 , * , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 4 , 26
      Journal of Toxicologic Pathology
      Japanese Society of Toxicologic Pathology
      nonhuman primate, pathology, toxicopathology, nomenclature, background findings, INHAND, cynomolgus macaque

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions Project (www.toxpath.org/inhand.asp) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP) and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying microscopic lesions observed in most tissues and organs from the nonhuman primate used in nonclinical safety studies. Some of the lesions are illustrated by color photomicrographs. The standardized nomenclature presented in this document is also available electronically on the internet (http://www.goreni.org/). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes spontaneous lesions as well as lesions induced by exposure to test materials. Relevant infectious and parasitic lesions are included as well. A widely accepted and utilized international harmonization of nomenclature for lesions in laboratory animals will provide a common language among regulatory and scientific research organizations in different countries and increase and enrich international exchanges of information among toxicologists and pathologists.

          Related collections

          Most cited references549

          • Record: found
          • Abstract: found
          • Article: found

          The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

          The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor. For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era. As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA fusion-positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered. The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance. Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded. Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The 2007 WHO Classification of Tumours of the Central Nervous System

            The fourth edition of the World Health Organization (WHO) classification of tumours of the central nervous system, published in 2007, lists several new entities, including angiocentric glioma, papillary glioneuronal tumour, rosette-forming glioneuronal tumour of the fourth ventricle, papillary tumour of the pineal region, pituicytoma and spindle cell oncocytoma of the adenohypophysis. Histological variants were added if there was evidence of a different age distribution, location, genetic profile or clinical behaviour; these included pilomyxoid astrocytoma, anaplastic medulloblastoma and medulloblastoma with extensive nodularity. The WHO grading scheme and the sections on genetic profiles were updated and the rhabdoid tumour predisposition syndrome was added to the list of familial tumour syndromes typically involving the nervous system. As in the previous, 2000 edition of the WHO ‘Blue Book’, the classification is accompanied by a concise commentary on clinico-pathological characteristics of each tumour type. The 2007 WHO classification is based on the consensus of an international Working Group of 25 pathologists and geneticists, as well as contributions from more than 70 international experts overall, and is presented as the standard for the definition of brain tumours to the clinical oncology and cancer research communities world-wide.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Initial sequencing and comparative analysis of the mouse genome.

              The sequence of the mouse genome is a key informational tool for understanding the contents of the human genome and a key experimental tool for biomedical research. Here, we report the results of an international collaboration to produce a high-quality draft sequence of the mouse genome. We also present an initial comparative analysis of the mouse and human genomes, describing some of the insights that can be gleaned from the two sequences. We discuss topics including the analysis of the evolutionary forces shaping the size, structure and sequence of the genomes; the conservation of large-scale synteny across most of the genomes; the much lower extent of sequence orthology covering less than half of the genomes; the proportions of the genomes under selection; the number of protein-coding genes; the expansion of gene families related to reproduction and immunity; the evolution of proteins; and the identification of intraspecies polymorphism.
                Bookmark

                Author and article information

                Journal
                J Toxicol Pathol
                J Toxicol Pathol
                TOX
                Journal of Toxicologic Pathology
                Japanese Society of Toxicologic Pathology
                0914-9198
                1881-915X
                28 September 2021
                2021
                : 34
                : 3 Suppl
                : 1S-182S
                Affiliations
                [1 ] Novartis Institutes for BioMedical Research, Cambridge, MA, USA
                [2 ] Wake Forest School of Medicine, Department of Radiation Oncology, Winston-Salem, NC, USA
                [3 ] Penn State College of Medicine, Department of Comparative Medicine, Hershey, PA, USA
                [4 ] Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
                [5 ] Charles River Laboratories Edinburgh Ltd., Tranent, Scotland, UK
                [6 ] Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland
                [7 ] Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium
                [8 ] Department of Pathology, Section on Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA
                [9 ] LSIM Safety Institute Corporation, Ibaraki, Japan
                [10 ] Hennigsdorf, Germany
                [11 ] InSight Pathology BV, Oss, the Netherlands
                [12 ] Department of Pathology, Duke University School of Medicine, Durham, NC, USA
                [13 ] Charles River Laboratories, Lyon, France
                [14 ] Experimental Pathology Laboratories, Inc., Research Triangle Park, NC, USA
                [15 ] Covance Preclinical Services GmbH, Münster, Germany
                [16 ] Cornell University College of Veterinary Medicine, Ithaca, NY, USA
                [17 ] Inotiv, Maryland Heights, MO, USA
                [18 ] Shin Nippon Biomedical Laboratories, Ltd., Kagoshima and Tokyo, Japan
                [19 ] Charles River Laboratories, Reno, NV, USA
                [20 ] Covance Laboratories, Inc., Madison, WI, USA
                [21 ] Ina Research Inc, Nagano, Japan
                [22 ] Charles River Laboratories, Evreux, France
                [23 ] Covance Laboratories, Ltd., Eye, UK
                [24 ] Covance Laboratories, Inc., Chantilly, VA, USA
                [25 ] Charles River, Mattawan, MI, USA
                [26 ] Lilly Research Laboratories, Indianapolis IN, USA
                Author notes
                *Address correspondence to: Karyn Colman, Novartis Institutes for BioMedical Research, Cambridge, MA, USA. e-mail: Karyn.colman@ 123456novartis.com
                Article
                2021-I002
                10.1293/tox.34.1S
                8544165
                34712008
                b9505720-7c2a-4d1b-a42e-99fae569ade6
                ©2021 The Japanese Society of Toxicologic Pathology

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.

                History
                Categories
                Review

                Pathology
                nonhuman primate,pathology,toxicopathology,nomenclature,background findings,inhand,cynomolgus macaque

                Comments

                Comment on this article